HUMAN PAPILLOMAVIRUS-RELATED SQUAMOUS CELL CARCINOMA OF THE PENIS

Clinical trials for HUMAN PAPILLOMAVIRUS-RELATED SQUAMOUS CELL CARCINOMA OF THE PENIS explained in plain language.

Never miss a new study

Get alerted when new HUMAN PAPILLOMAVIRUS-RELATED SQUAMOUS CELL CARCINOMA OF THE PENIS trials appear

Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS-RELATED SQUAMOUS CELL CARCINOMA OF THE PENIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested against rare, Tough-to-Treat cancers

Disease control Ongoing

This study is testing whether a combination of two immunotherapy drugs, atezolizumab and bevacizumab, can help control several rare types of advanced solid tumors. The trial is for adults whose cancer has spread or returned after other treatments. The goal is to see if this drug …

Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED SQUAMOUS CELL CARCINOMA OF THE PENIS

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

HUMAN PAPILLOMAVIRUS-RELATED SQUAMOUS CELL CARCINOMA OF THE PENIS

Get alerted when new HUMAN PAPILLOMAVIRUS-RELATED SQUAMOUS CELL CARCINOMA OF THE PENIS trials appear

New drug combo tested against rare, Tough-to-Treat cancers